The prescription of insulin pen devices versus syringes for older people with diabetes

Diabetes Technology and Therapeutics

Volumn 11, Issue 7, 2009, Pages 439-442

  Shaghouli, Amna A ^a   Shah, Baiju R ^b,c,d  

^a Al Ameri Hospital   (Kuwait)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

AGED; ARTICLE; CANADA; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; INSULIN PEN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF INJECTION; SYRINGE; DEMOGRAPHY; DRUG DELIVERY SYSTEM; INSTRUMENTATION; METHODOLOGY; PATIENT EDUCATION; RISK;

AGED; COHORT STUDIES; DEMOGRAPHY; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ODDS RATIO; ONTARIO; PATIENT EDUCATION AS TOPIC; PRESCRIPTIONS; RETROSPECTIVE STUDIES; SYRINGES;

EID: 70349332486     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0110     Document Type: Article

References (16)

1. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
2. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
3. Brunton S: Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121(6 Suppl):S35-S41.
4. Davis EM, Christensen CM, Nystrom KK, Foral PA, Destache C: Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm 2008;65:1347-1357.
5. Stockl K, Caron O, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E: An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-146.
6. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL: Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-1725.
7. Summers KH, Szeinbach SL, Lenox SM: Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-1505.
8. Korytkowski M, Bell D, Jacobsen C, Suwannasari R; Flex Pen Study Team: A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial=syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848.
9. Kadiri A, Chraibi A, Marouan F, Ababou MR, El Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y: Comparison of NovoPen 3 and syringes=vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23.
10. Da Costa S, Brackenridge B, Hicks D: A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ 2002;28:52-60.
11. Rubin RR, Peyrot M: Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-432.
12. Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JD: Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 2001;21:45-56.
13. The Institute for Safe Medication Practices: Considering insulin pens for routine hospital use? Consider this. . . . http:== www.ismp.org=Newsletters= acutecare=articles=20080508.asp (accessed December 22, 2008).
14. Puxty JA, Hunter DH, Burr WA: Accuracy of insulin injection in elderly patients. BMJ 1983;287:1762.
15. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care 2005;28:2543-2545.
16. Korytkowski M: When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002;26 (Suppl 3):S18-S24.